Searched for
NEW DELHI PHARMA NEWS
Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...- Indian envoy to Shanghai discusses New Delhi-Beijing ties with Chinese scholarsIndia's Consul General in Shanghai, Pratik Mathur, engaged in significant discussions with Chinese scholars at the Shanghai Institute of In...
- Tremors jolt Delhi-NCR, Kashmir as magnitude 6.2 earthquake hits AfghanistanStrong earthquake tremors were felt across Delhi-NCR and Srinagar on Saturday evening following a magnitude 6.2 quake in Afghanistan's Hind...
- Right to walk, but where? Supreme Court ruling shines light on Delhi's footpathsDelhi's Supreme Court ruling declares walking on footpaths a fundamental right, yet citizens face daily struggles with damaged, missing, or...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- BJP councillor injured in stray cattle attack in DelhiA BJP councillor from East Delhi, Shashi Chandna, suffered severe injuries after being attacked by stray cattle on Wednesday. While returni...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Tata-STT's Delhi data centre suffers 'extensive damage'; data recovery challengedA significant fire at a New Delhi data centre, a joint venture between ST Telemedia and Tata Communications, has caused extensive damage, c...
- China ready to implement leaders' consensus, properly handle sensitive issues: Wang YiChinese Foreign Minister Wang Yi met with Prime Minister Narendra Modi in New Delhi, expressing readiness to work with India on sensitive i...
- Birthday cake never arrived despite extra delivery fee; consumer commission orders Rs 4,000 compensationA man will receive Rs 4,000 in compensation after an e-commerce company failed to deliver his grandmother's birthday cake, despite charging...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...
- Delhi NCR’s next growth story: Four new cities planned as population expected to doubleFour new "Namo Cities" will be developed across the NCR with Rs 5,000 crore in central assistance over five years. The existing NCR boundar...
Load More
